Amarin | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amarin USD 308.15M 2.85M 2025-03
AstraZeneca USD 1.55B 1.16B 2025-06
DBV Technologies USD 11.65M 1000 2025-03
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Halozyme Therapeutics USD 117.62M 117.5M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12


Amarin Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.